AUS
NZ
UK
CA
USA
IND
Healthcare
Why Smith & Nephew’s Latest Debt Move Is Turning Heads
June 03, 2026 11:53 AM BST| By Team Kalkine MediaSmith & Nephew has strengthened its long-term funding framework through a London-listed debt issuance, highlighting continued access to capital markets and reinforcing financial flexibility within the healthcare industry.
Why Healthcare Shares Keep Their Cool Through The Noise
June 03, 2026 04:57 AM BST| By Vivek SinghUK healthcare shares are drawing attention for their defensive qualities, with pharmaceutical giants and specialist names in focus as investors seek resilience amid geopolitical uncertainty.
AstraZeneca’s FDA Setback: A Temporary Hiccup or a Bigger Story?
June 02, 2026 07:25 AM BST| By Vivek SinghAstraZeneca's camizestrant setback drew attention, but positive developments for Enhertu and Imfinzi highlight the strength of its wider oncology business. Meanwhile, GSK continues building momentum through regulatory approvals and pipeline progress.
GSK Maintains Strong Presence Within FTSE 100 Pharmaceutical Landscape
June 01, 2026 12:19 PM BST| By Vivek SinghGSK remains an established participant in the pharmaceutical and vaccines sector, maintaining a strong presence across healthcare markets and within the FTSE-focused UK equity landscape.
3 UK MedTech Names Worth Watching Through 2026
May 31, 2026 05:39 PM BST| By Vivek SinghUK medical technology names continue delivering through 2026 with substantial orthopaedic, wound management and broader medical device operations supporting global healthcare customer relationships.
3 UK Pharma Majors Driving Global Healthcare Innovation
May 31, 2026 05:38 PM BST| By Vivek SinghUK FTSE pharmaceutical majors continue delivering through 2026 with substantial global product portfolios across oncology, vaccines and broader therapeutic categories supporting consistent operational delivery.
3 UK Healthcare Specialty Names Beyond Big Pharma
May 28, 2026 05:39 PM BST| By Vivek SinghUK healthcare specialty names provide differentiated exposure to dental services, sleep apnea and broader specialty healthcare beyond the major pharmaceutical and medical technology cohort.
AIM Healthcare Shares to Watch for Emerging Healthcare Trends
May 28, 2026 01:40 PM BST| By Vivek SinghExplore AIM healthcare shares shaping market attention through clinical services, diagnostics innovation and healthcare expansion trends across the UK small-cap healthcare sector.
Healthcare Dividend Focus Surrounds Bioventix Within FTSE AIM Share Segment
May 28, 2026 01:21 PM BST| By Vivek SinghBioventix (LSE:BVXP) remains active within the UK biotechnology and diagnostics sector through antibody development, healthcare laboratory links, and dividend market visibility.
Dr. Martens (LSE:DOCS) Shows Stronger Financial Strength Than Headlines Suggest
May 28, 2026 12:18 PM BST| By Vivek SinghDr. Martens (LSE:DOCS) demonstrated healthy cash flow generation and operational resilience, with earnings reflecting temporary pressures rather than underlying weakness in business fundamentals.
GSK Share Admission Draws Attention Across FTSE 100 Markets
May 27, 2026 01:12 PM BST| By Vivek SinghA leading UK healthcare company expanded its listed share base through an employee share programme, highlighting ongoing corporate activity and sustained visibility within Britain’s equity market landscape.
FTSE 100 Slides as Oil Swings Shake UK Market Mood
May 27, 2026 12:36 PM BST| By Vivek SinghLondon markets traded cautiously as oil volatility pressured energy stocks, while retail and travel companies offered support amid geopolitical uncertainty and evolving corporate developments across UK equities.
Physiomics Builds Momentum Through New Biotechnology Agreements
May 27, 2026 11:34 AM BST| By Vivek SinghPhysiomics secures fresh biotechnology contracts, expanding its international research presence while supporting oncology-focused drug development through modelling, biometrics, and data science expertise.
Why Are AstraZeneca HSBC And Diageo Trending
May 27, 2026 10:49 AM BST| By Vivek SinghLondon blue-chip discussions strengthened through pharmaceutical resilience, diversified banking activity and premium consumer participation as AstraZeneca, HSBC and Diageo remained widely discussed today.
FTSE 100: AstraZeneca (LSE:AZN) Faces Fresh Market Spotlight
May 27, 2026 07:08 AM BST| By Vivek SinghAstraZeneca (LSE:AZN) remains in focus within the healthcare sector as investors examine its innovation pipeline, global expansion strategy, and evolving market sentiment.
Why Are UK Healthcare Stocks Drawing Attention
May 26, 2026 06:38 PM BST| By Vivek SinghLondon healthcare companies remain connected with pharmaceutical development, biotechnology research, diagnostics activity, and medical technology operations across the [FTSE 100] and specialist healthcare segments.
Oncology Medicine Development Keeps AstraZeneca Within FTSE 350
May 26, 2026 11:28 AM BST| By Vivek SinghAstraZeneca remains active across oncology, respiratory medicine, and rare disease therapy through clinical programmes, healthcare partnerships, and regulatory activity in international markets.
AstraZeneca (LSE:AZN) Draws Market Focus as Share Momentum Moderates
May 26, 2026 10:53 AM BST| By Vivek SinghAstraZeneca (LSE:AZN) remains a major healthcare discussion point as investors monitor valuation trends, pipeline developments, and long-term market positioning within the global pharmaceutical landscape.
CVS Group Advances Expansion Plans with Strategic Refinancing
May 26, 2026 08:36 AM BST| By Vivek SinghCVS Group advances its international veterinary growth plans through refinancing, Australia acquisitions, and operational investments while strengthening its market presence across the veterinary healthcare sector.
Why Are UK Growth Shares Drawing Attention
May 26, 2026 07:55 AM BST| By Vivek SinghUK growth shares continue attracting broader discussion through healthcare expansion, technology development, industrial activity, banking operations, and energy-sector transformation across domestic markets today.
